Australian Urokinase Stroke Trial "AUST"

Suspended

Phase N/A Results N/A

Summary of Purpose

To compare the efficacy of urokinase in combination with heparin with that of heparin alone in reducing the morbidity and mortality in patients with ischemic stroke and lysable lesions.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The Serono company has withdrawn its sponsorship. Alternative sponsorship is being sought.

Trial Design

Randomized, blinded study of approximately 200 patients.

Contacts

  • Co-ordination Centre Dept of Neurology Austin & Repatriation Medical Centre, Heidelberg, Victoria 3084 Australia

    donnan@austin.unimelb.edu.au